Rakesh Sindhi
About Rakesh Sindhi
Rakesh Sindhi serves as the Co-Director of Pediatric Transplantation at Children's Hospital of Pittsburgh and holds the position of Chief Scientific Officer at Plexision. He focuses on mechanism-based decision-making to enhance treatment outcomes and has developed advanced cell-based functional test systems for personalized immune therapy.
Work at UPMC Children's Hospital of Pittsburgh
Rakesh Sindhi serves as Co-Director of Pediatric Transplantation at UPMC Children's Hospital of Pittsburgh. He has held this position since 2004, contributing to the advancement of pediatric transplantation practices for 20 years. In this role, he focuses on improving treatment outcomes through mechanism-based decision-making. His expertise in pediatric transplantation has positioned him as a key figure in the hospital's efforts to provide high-quality care to young patients in need of transplant services.
Current Role at Plexision
Since 2017, Rakesh Sindhi has been the Chief Scientific Officer at Plexision, where he leads initiatives aimed at enhancing treatment methodologies. His work emphasizes the development of high-resolution cell-based functional test systems. These systems are designed to personalize immune therapy across various medical fields, including transplantation, infectious disease, and cancer. His focus on mechanism-based decision-making is integral to ensuring effective treatment outcomes in these areas.
Academic Position at University of Pittsburgh
Rakesh Sindhi has been a Professor of Surgery at the University of Pittsburgh since 2011. In this academic role, he contributes to the education and training of future surgeons, while also engaging in research that supports advancements in surgical practices. His long-standing association with the university highlights his commitment to academic excellence and the dissemination of knowledge in the field of surgery.
Research and Development in Transplantation
In his capacity at Plexision, Rakesh Sindhi has developed innovative high-resolution cell-based functional test systems. These systems are pivotal for personalizing immune therapy, which is crucial for improving patient outcomes in transplantation, infectious disease, and cancer. His research efforts reflect a commitment to advancing the science of transplantation and enhancing therapeutic strategies.